CDC42 and cancer: However, phenanthriplatin may also act to prevent cancer cell cytoskeletal stability by downregulating DIAPH2, while cisplatin regulation of cancer cell microtubule stability may act instead through microRNA and CDC42 signaling to modulate A549 cancer cell proliferation.